Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Duman

Showing results (131-140 of 469) with videos related to

Pageof 47
Sort By:
Neuropsychopharmacology Reports|November 14, 2023
Neuron-specific deletion of VEGF or its receptor Flk-1 occludes the antidepressant-like effects of desipramine and fluoxetine in miceSatoshi Deyama, Xiao-Yuan Li, Ronald S Duman
Psychopharmacology|January 1, 1992
Chronic imipramine treatment normalizes levels of tyrosine hydroxylase in the locus coeruleus of chronically stressed ratsK R Melia, E J Nestler, R S Duman
Strabismus|February 15, 2011
Surgical results in highly asymmetric dissociated vertical deviationsD Can, S B Ozkan, R Kasim, et al.
Brain Research|August 20, 1990
Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brainM D Hayward, R S Duman, E J Nestler
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2002
Molecular and behavioral interactions between central melanocortins and cocaineJohn D Alvaro, Jane R Taylor, Ronald S Duman
Brain Research|January 16, 1989
Glucocorticoid administration increases receptor-mediated and forskolin-stimulated cyclic AMP accumulation in rat brain cerebral cortical slicesR S Duman, S J Strada, S J Enna
Drug Discovery Today|February 9, 2016
Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticityDanielle M Gerhard, Eric S Wohleb, Ronald S Duman
The Lancet. Psychiatry|February 4, 2017
How do antidepressants work? New perspectives for refining future treatment approachesCatherine J Harmer, Ronald S Duman, Philip J Cowen
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 2011
Functional biomarkers of depression: diagnosis, treatment, and pathophysiologyHeath D Schmidt, Richard C Shelton, Ronald S Duman
The International Journal of Neuropsychopharmacology|November 26, 2011
mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockadeJason M Dwyer, Ashley E Lepack, Ronald S Duman
Pageof 47

Showing results (131-140 of 469) with videos related to

Sort By:
Pageof 47
Neuropsychopharmacology Reports|November 14, 2023
Neuron-specific deletion of VEGF or its receptor Flk-1 occludes the antidepressant-like effects of desipramine and fluoxetine in miceSatoshi Deyama, Xiao-Yuan Li, Ronald S Duman
Psychopharmacology|January 1, 1992
Chronic imipramine treatment normalizes levels of tyrosine hydroxylase in the locus coeruleus of chronically stressed ratsK R Melia, E J Nestler, R S Duman
Strabismus|February 15, 2011
Surgical results in highly asymmetric dissociated vertical deviationsD Can, S B Ozkan, R Kasim, et al.
Brain Research|August 20, 1990
Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brainM D Hayward, R S Duman, E J Nestler
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2002
Molecular and behavioral interactions between central melanocortins and cocaineJohn D Alvaro, Jane R Taylor, Ronald S Duman
Brain Research|January 16, 1989
Glucocorticoid administration increases receptor-mediated and forskolin-stimulated cyclic AMP accumulation in rat brain cerebral cortical slicesR S Duman, S J Strada, S J Enna
Drug Discovery Today|February 9, 2016
Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticityDanielle M Gerhard, Eric S Wohleb, Ronald S Duman
The Lancet. Psychiatry|February 4, 2017
How do antidepressants work? New perspectives for refining future treatment approachesCatherine J Harmer, Ronald S Duman, Philip J Cowen
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 2011
Functional biomarkers of depression: diagnosis, treatment, and pathophysiologyHeath D Schmidt, Richard C Shelton, Ronald S Duman
The International Journal of Neuropsychopharmacology|November 26, 2011
mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockadeJason M Dwyer, Ashley E Lepack, Ronald S Duman
Pageof 47